MOREPEN LABORATORIES
Back to Income Statement
|
MOREPEN LABORATORIES Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹96 Cr | ₹39 Cr | ₹102 Cr | ₹97 Cr | ₹34 Cr |
What is the latest Consolidated Net Profit of MOREPEN LABORATORIES ?
Year | Consolidated Net Profit |
---|---|
Mar2024 | ₹96 Cr |
Mar2023 | ₹39 Cr |
Mar2022 | ₹102 Cr |
Mar2021 | ₹97 Cr |
Mar2020 | ₹34 Cr |
How is Consolidated Net Profit of MOREPEN LABORATORIES Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2024 | ₹96 Cr | 148.64 | |
Mar2023 | ₹39 Cr | -61.97 | |
Mar2022 | ₹102 Cr | 4.73 | |
Mar2021 | ₹97 Cr | 189.13 | |
Mar2020 | ₹34 Cr | - |
Compare Consolidated Net Profit of peers of MOREPEN LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MOREPEN LABORATORIES | ₹3,575.2 Cr | 5.6% | 1.3% | 12.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹402,284.0 Cr | -0% | -0.4% | 10.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹183,268.0 Cr | 1.4% | 4.1% | 50.3% | Stock Analytics | |
CIPLA | ₹122,253.0 Cr | 0.5% | 1.6% | 1.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹113,988.0 Cr | -1.2% | 7.1% | 18.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹108,921.0 Cr | 1.7% | 1.2% | 1.5% | Stock Analytics |
MOREPEN LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MOREPEN LABORATORIES | 5.6% |
1.3% |
12.6% |
SENSEX | -0.7% |
3% |
5% |
You may also like the below Video Courses